DEFLAZACORT
HIKMA · DEFLAZACORT
Open FDA's page for this record- Application number
- ANDA220524
- Sponsor name
- HIKMA
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20260918
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 003
- Reference drug
- No
- Brand name
- DEFLAZACORT
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- DEFLAZACORT
- Strength
- 30MG
- Product number
- 001
- Reference drug
- No
- Brand name
- DEFLAZACORT
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- DEFLAZACORT
- Strength
- 6MG
- Product number
- 004
- Reference drug
- No
- Brand name
- DEFLAZACORT
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- DEFLAZACORT
- Strength
- 36MG
- Product number
- 002
- Reference drug
- No
- Brand name
- DEFLAZACORT
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- DEFLAZACORT
- Strength
- 18MG
- Harmonized identifiers (openFDA)
- Application number
- ANDA220524
- Brand name
- DEFLAZACORT
- Generic name
- DEFLAZACORT
- Manufacturer name
- Hikma Pharmaceuticals USA Inc.
- Product NDC
- 0054-0824, 0054-0825, 0054-0826, 0054-0827
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- DEFLAZACORT
- RxCUI
- 153098, 153880, 1870954, 1870958
- SPL ID
- b019324e-dbd3-4404-a0b5-021d67c0270b
- SPL set ID
- 00df3169-b8e3-4584-823b-91b71807d1a6
- Package NDC
- 0054-0824-25, 0054-0825-13, 0054-0826-13, 0054-0827-13
- Nui
- N0000175576, N0000175450
- Pharm class epc
- Corticosteroid [EPC]
- Pharm class moa
- Corticosteroid Hormone Receptor Agonists [MoA]
- UNII
- KR5YZ6AE4B
